Results 91 to 100 of about 24,116 (179)

HIV gp120 induces TREM1 expression through TLR-PGE₂ signalling in human monocyte-derived microglia. [PDF]

J Neuroinflammation
Mahama A, Rawat P, Teodorof-Diedrich C, Spector SA, Campbell GR.   +4 more
europepmc   +1 more source

Genotypic challenges in implementing broadly neutralizing antibody-based long-acting HIV-1 therapies. [PDF]

Commun Med (Lond)
Tao K, Herschhorn A, Fera D, Lynch RM, Julg BD, Korber B, Shafer RW.   +6 more
europepmc   +1 more source

Research progress on HIV-1 structural proteins and antiviral therapies. [PDF]

Front Immunol
Wang H, Yuan J, Wang H.
europepmc   +1 more source

CD4; HIV gp120 [PDF]

Science-Business eXchange, 2013
openaire   +1 more source

Comparing CD8+ T cell ENV epitopes of two HLA class I alleles associated with different outcomes of HIV-1 infection with broadly neutralizing antibodies epitope targets discovered to date. [PDF]

Front Immunol
Ramdoyal A, Daniuk CA, Omange RW, Kimani J, Luo M.   +4 more
europepmc   +1 more source

HIV gp120 vaccine (Chiron)

Drugs in R & D, 1999
openaire   +2 more sources

Author Correction: NLRP3-dependent pyroptosis is required for HIV-1 gp120-induced neuropathology. [PDF]

Cell Mol Immunol
He X, Yang W, Zeng Z, Wei Y, Gao J, Zhang B, Li L, Liu L, Wan Y, Zeng Q, Gong Z, Liu L, Zhang H, Li Y, Yang S, Hu T, Wu L, Masliah E, Huang S, Cao H.   +19 more
europepmc   +1 more source

HIV gp120; CD4 [PDF]

Science-Business eXchange, 2012
openaire   +1 more source

Endocytic motif on HIV-1 Env regulates cleavage status and antibody neutralization of cell-free and cell-to-cell infection. [PDF]

J Virol
Figueroa Acosta DM, Valencia TR, Li H, Chen BK.   +3 more
europepmc   +1 more source

HIV gp120; CD4 [PDF]

Science-Business eXchange, 2010
openaire   +1 more source